Validation of an Urticaria Control Test

Chronic Urticaria Clinical Trial

— UCT-V  

Official title:

Development (and Validation) of an Instrument to Assess Disease Control in Patients With Urticaria (Urticaria Control Test)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01614834
• Other study ID #: UCT-V
• Status: Completed
• Phase: N/A
• First received: June 6, 2012
• Last updated: January 5, 2017
• Start date: July 2012
• Est. completion date: September 2013

Study information

• Verified date: January 2017
• Source: Charite University, Berlin, Germany
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Observational

Clinical Trial Summary

The aim of this study is to validate a previously developed patient reported outcome instrument (in project UCT-D) to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: September 2013
• Est. primary completion date: August 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years and older
• Eligibility: all patients suffering from chronic forms of urticaria are eligible

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Chronic Urticaria
• Urticaria

Locations

Country	Name	City	State
Germany	Allergie-Centrum-Charite	Berlin
Germany	Universitätshautklinik Mainz	Mainz	Rheinland-Pfalz

Sponsors (1)

Lead Sponsor	Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany,